The National Institute for Health and Care Excellence (NICE) has proposed age-based thresholds for ovarian cancer screening to help identify women at higher risk earlier. Previously,...
Analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer development, new research has revealed....
Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER...
A combination of THC and CBD derived from cannabis was shown to kill ovarian cancer cells without harming healthy cells in laboratory studies. The findings suggest...
HRT (hormone replacement therapy) may not increase breast cancer risk in women with BRCA mutations, new research suggests. Women who inherit harmful mutations in the BRCA1...
Routine mammograms could help assess cardiovascular disease risk in women, new research suggests. The study found that both the severity of calcium in breast arteries and...
Telling women their breast density after screening was linked to higher anxiety and confusion than no notification, an Australian study suggests. Breast density is the proportion...
Femtech World explores the latest research developments in the world of women’s health. Fertility treatments linked to higher mutations than natural conception Mice that were conceived...
A new AI model can predict a person’s risk of developing breast cancer up to five years in advance by analysing mammograms. The technology could make...
An overlooked fat-derived hormone may drive higher breast cancer death risk in postmenopausal women with obesity, an analysis suggests. The review identifies oestrone, a form of...
